1 Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose-volume effects in the lung[J]. Int J Radiat Oncol Biol Phys, 2010, 76(3 Suppl): S70-S76.
2 Wang P, Yan Z, Zhou PK, et al. The promising therapeutic approaches for radiation-induced pulmonary fibrosis: Targeting radiation-induced mesenchymal transition of alveolar type Ⅱ epithelial cells[J]. Int J Mol Sci, 2022, 23(23): 15014.
3 Hanania AN, Mainwaring W, Ghebre YT, et al. Radiation-induced lung injury: Assessment and management[J]. Chest, 2019, 156(1): 150-162.
4 Kasmann L, Dietrich A, Staab-Weijnitz CA, et al. Radiation-induced lung toxicity-cellular and molecular mechanisms of pathogenesis, management, and literature review[J]. Radiat Oncol, 2020,15(1): 214.
5 Deutsch E, Meziani L. Radiation-induced pulmonary fibrosis: New potential targets[J]. Cancer Radiother, 2023, 27(6-7): 491-493.
6 徐燕梅, 崔天祥, 张晓晶, 等. 外周血单核细胞数量与肺癌放疗近、远期疗效的相关性分析[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(2): 159-164.
7 Jarzebska N, Karetnikova ES, Markov AG, et al. Scarred lung. An update on radiation-induced pulmonary fibrosis[J]. Front Med(Lausanne), 2020, 7: 585756.
8 Groves AM, Johnston CJ, Williams JP, et al. Role of infiltrating monocytes in the development of radiation-induced pulmonary fibrosis[J]. Radiat Res, 2018, 189(3): 300-311.
9 Paix A, Antoni D, Waissi W, et al. Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review[J]. Crit Rev Oncol Hematol, 2018, 123: 138-148.
10 Ding X, Ji W, Li J, et al. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer[J]. Radiat Oncol, 2011, 6: 24.
11 Yamaguchi S, Ohguri T, Matsuki Y, et al. Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis[J]. Int J Clin Oncol, 2015, 20(1): 45-52.
12 Ahmadi MM, Rezaee R, Rezaianzadeh A, et al. Developing a model for hospitals' emergency department preparedness in radiation and nuclear incidents and nuclear terrorism in Iran[J]. Bull Emerg Trauma, 2019, 7(3): 300-306.
13 Kim H, Park SH, Han SY, et al. LXA(4)-FPR2 signaling regulates radiation-induced pulmonary fibrosis via crosstalk with TGF-beta/Smad signaling[J]. Cell Death Dis, 2020, 11(8): 653.
14 Chen Z, Wu Z, Ning W. Advances in molecular mechanisms and treatment of radiation-induced pulmonary fibrosis[J]. Transl Oncol, 2019, 12(1): 162-169.
15 Park HR, Jo SK, Jung U. Ionizing radiation promotes epithelial-to-mesenchymal transition in lung epithelial cells by TGF-beta-producing M2 macrophages[J]. In Vivo, 2019, 33(6): 1773-1784.
16 Son B, Kwon T, Lee S, et al. CYP2E1 regulates the development of radiation-induced pulmonary fibrosis via ER stress-and ROS-dependent mechanisms[J]. Am J Physiol Lung Cell Mol Physiol, 2017, 313(5): L916-L929.
17 Sunil GSN, Raghavi R, Devipriya N, et al. Radiation-induced lung injury: impact on macrophage dysregulation and lipid alteration-a review[J]. Immunopharmacol Immunotoxicol, 2019, 41(3): 370-379.
18 Han G, Zhang H, Xie CH, et al. Th2-like immune response in radiation-induced lung fibrosis[J]. Oncol Rep, 2011, 26(2): 383-388.
19 Yuan M, Zhao M, Sun X, et al. The mapping of mRNA alterations elucidates the etiology of radiation-induced pulmonary fibrosis[J]. Front Genet, 2022, 13: 999127.
20 Li M, Liu P, Ke Y, et al. Research progress on macrophage in radiation induced lung injury[J]. J Zhejiang University(Medical Sciences), 2020, 49(5): 623-628.
21 Wang D, Li Z, Zhang Y, et al. Bibliometric analysis of research relating to radiation-induced lung injury[2001-2020][J]. Ann Palliat Med, 2021, 10(10): 11166-11176.
22 Wang Z, Chen J, Su L, et al. Downregulation of miR-761 ameliorates radiation-induced pulmonary fibrosis by regulating PGC-1alpha[J]. Exp Lung Res, 2022, 48(4-6): 158-167.
23 Kim JS, Son Y, Jung MG, et al. Geranylgeranylacetone alleviates radiation-induced lung injury by inhibiting epithelial-to-mesenchymal transition signaling[J]. Mol Med Rep, 2016, 13(6): 4666-4670.
24 Weytjens R, Erven K, De RD. Radiation pneumonitis: occurrence, prediction, prevention and treatment[J]. Belg J Med Oncol, 2013, 7(4): 105-110.
25 Williams JP, Johnston CJ, Finkelstein JN. Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction?[J]. Curr Drug Targets, 2010, 11(11): 1386-1394.
26 Qin W, Liu B, Yi M, et al. Antifibrotic agent pirfenidone protects against development of radiation-induced pulmonary fibrosis in a murine model[J]. Radiat Res, 2018, 190(4): 396-403.
27 UpToDate.(2024). Clinical manifestations, prevention, and treatment of radiation-induced fibrosis. Retrieved October 17, 2024, from https://www.uptodate.com/contents/clinical-manifestations-prevention-and-treatment-of-radiation-induced-fibrosis.
28 应航洁, 陈亚梅, 陈梦圆, 等. 放射性肺损伤发生机制研究进展[J]. 中华放射肿瘤学杂志, 2021, 30(2): 213-216.
29 敖兴坤, 严紫艳, 顾永清. 上皮间质转化在放射性肺纤维化中的作用及治疗策略[J]. 中华放射医学与防护杂志, 2023, 43(4): 307-313.
30 Chen ZJ, Wu ZQ, Wen N. Advances in molecular mechanisms and treatment of radiation-induced pulmonary fibrosis[J]. Translational Oncology, 2019, 12(1): 162-169.
31 中国医疗保健国际交流促进会胸部肿瘤分会, 中国肿瘤放射治疗联盟. 放射相关性肺炎中国专家诊治共识[J]. 中华肿瘤防治杂志, 2022, 29(14): 1015-1022.
32 Fernando LM, Adeel S, Basar M A, et al. In-gel SOD assay reveals SOD-2 is the single active, water-soluble SOD enzyme in C. elegans[J]. Free Radic Res, 2021, 55(6): 619-624.
33 Liu J, Wang X, Wang F, et al. Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro[J]. Biomed Pharmacother, 2009, 63(7): 484-491.
34 Yu Z, Xu C, Song B, et al. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances[J]. J Transl Med, 2023, 21(1): 708.
35 Pan J, He H, Su Y, et al. In Vivo Radioprotective Activity of Cell-Permeable Bifunctional Antioxidant Enzyme GST-TAT-SOD against Whole-Body Ionizing Irradiation in Mice[J]. Oxid Med Cell Longev, 2017, 2017: 2689051.
36 Ruan Z, Liu Y, Chang G, et al. Molecular characterization of two CuZn-SOD family proteins in the Pacific oyster Crassostrea gigas[J]. Comp Biochem Physiol B Biochem Mol Biol, 2022, 260: 110736.
37 Chen D, Ai X, Li Y, et al. Protective effects of Cu/Zn-SOD and Mn-SOD on UVC radiation-induced damage in NIH/3T3 cells and murine skin[J]. Acta Histochem, 2023, 125(4): 152030.
38 Liu T, Yang Q, Zheng H, et al. Multifaceted roles of a bioengineered nanoreactor in repressing radiation-induced lung injury[J]. Biomaterials, 2021, 277: 121103.
39 Tahamtan R, Shabestani MA, Tahamtani Y, et al. Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats[J]. Cell J, 2015, 17(1): 111-120.
40 Yahyapour R, Amini P, Saffar H, et al. Protective effect of metformin, resveratrol and alpha-lipoic acid on radiation- induced pneumonitis and fibrosis: A histopathological study[J]. Curr Drug Res Rev, 2019, 11(2): 111-117.
41 Seyedpour N, Motevaseli E, Taeb S, et al. Protective effects of alpha-lipoic acid, resveratrol, and apigenin against oxidative damages, histopathological changes, and mortality induced by lung irradiation in rats[J]. Curr Radiopharm, 2023, 17(1): 99-110.
42 Azmoonfar R, Amini P, Yahyapour R, et al. Mitigation of radiation-induced pneumonitis and lung fibrosis using alpha-lipoic acid and resveratrol[J]. Antiinflamm Antiallergy Agents Med Chem, 2020, 19(2): 149-157.
43 Magnusson M, Hoglund P, Johansson K, et al. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial(Ptx-5)[J]. Eur J Cancer, 2009, 45(14): 2488-2495.
44 Lee JG, Shim S, Kim MJ, et al. Pentoxifylline regulates plasminogen activator inhibitor-1 expression and protein kinase a phosphorylation in radiation-induced lung fibrosis[J]. Biomed Res Int, 2017, 2017: 1279280.
45 Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol[J]. J Clin Oncol, 1999, 17(10): 3283-3290.
46 Chen C, Yang S, Zhang M, et al. Triptolide mitigates radiation-induced pulmonary fibrosis via inhibition of axis of alveolar macrophages-NOXes-ROS-myofibroblasts[J]. Cancer Biol Ther, 2016, 17(4): 381-389.
47 Guo K, Chen J, Chen Z, et al. Triptolide alleviates radiation-induced pulmonary fibrosis via inhibiting IKKbeta stimulated LOX production[J]. Biochem Biophys Res Commun, 2020, 527(1): 283-288.
48 Park JH, Ryu SH, Choi EK, et al. SKI2162, an inhibitor of the TGF-beta type I receptor(ALK5), inhibits radiation-induced fibrosis in mice[J]. Oncotarget, 2015, 6(6): 4171-4179.
49 Park J, Choi J, Cho I, et al. Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-beta/ALK5 inhibitor[J]. Sci Rep, 2022, 12(1): 16104.
50 Dadrich M, Nicolay NH, Flechsig P, et al. Combined inhibition of TGFbeta and PDGF signaling attenuates radiation-induced pulmonary fibrosis[J]. Oncoimmunology, 2016, 5(5): e1123366.
51 Anscher MS, Thrasher B, Zgonjanin L, et al. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury[J]. Int J Radiat Oncol Biol Phys, 2008, 71(3): 829-837.
52 Li M, Ping G, Plathow C, et al. Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling(SU9518)modifies radiation response in fibroblasts and endothelial cells[J]. BMC Cancer, 2006, 6: 79.
53 Abdollahi A, Li M, Ping G, et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis[J]. J Exp Med, 2005, 201(6): 925-935.
54 Dadrich M, Nicolay NH, Flechsig P, et al. Combined inhibition of TGFbeta and PDGF signaling attenuates radiation-induced pulmonary fibrosis[J]. Oncoimmunology, 2016, 5(5): e1123366.
55 Sternlicht MD, Wirkner U, Bickelhaupt S, et al. Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab[J]. Respir Res, 2018, 19(1): 14.
56 Bickelhaupt S, Erbel C, Timke C, et al. Effects of CTGF blockade on attenuation and reversal of radiation-induced pulmonary fibrosis[J]. J Natl Cancer Inst, 2017,109(8).doi: 10.1093/jnci/djw339.
57 Li Q, Cheng Y, Zhang Z, et al. Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3[J]. Clin Transl Med, 2022, 12(10): e1036.
58 Ostrau C, Hulsenbeck J, Herzog M, et al. Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo[J]. Radiother Oncol, 2009, 92(3): 492-499.
59 Dong LH, Jiang YY, Liu YJ, et al. The anti-fibrotic effects of mesenchymal stem cells on irradiated lungs via stimulating endogenous secretion of HGF and PGE2[J]. Sci Rep, 2015, 5: 8713.
60 Agha Elie EI, Kramann R, Schneider RK, et al. Mesenchymal stem cells in fibrotic disease[J]. Cell Stem Cell, 2017, 21(2): 166-177.
61 Rong X, Liu J, Yao X, et al. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/beta-catenin pathway[J]. Stem Cell Res Ther, 2019, 10(1): 98.
62 Zhang Y, Jiang X, Ren L. Optimization of the adipose-derived mesenchymal stem cell delivery time for radiation-induced lung fibrosis treatment in rats[J]. Sci Rep, 2019, 9(1): 5589.
63 Guo Z, Zhang Y, Yan F. Potential of mesenchymal stem cell-based therapies for pulmonary fibrosis[J]. DNA Cell Biol, 2022, 41(11): 951-965.
64 Molteni A, Wolfe LF, Ward WF, et al. Effect of an angiotensin Ⅱ receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta(TGF-beta)and alpha-actomyosin(alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis[J]. Curr Pharm Des, 2007, 13(13): 1307-1316.
65 Hedayatyanfard K, Ziai SA, Niazi F, et al. Losartan ointment relieves hypertrophic scars and keloid: A pilot study[J]. Wound Repair Regen, 2018, 26(4): 340-343.
66 Couluris M, Kinder BW, Xu P, et al. Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project[J]. Lung, 2012, 190(5): 523-527.
67 Gao F, Fish BL, Moulder JE, et al. Enalapril mitigates radiation-induced pneumonitis and pulmonary fibrosis if started 35 days after whole-thorax irradiation[J]. Radiat Res, 2013, 180(5): 546-552.
68 Mahmood J, Jelveh S, Zaidi A, et al. Targeting the Renin-angiotensin system combined with an antioxidant is highly effective in mitigating radiation-induced lung damage[J]. Int J Radiat Oncol Biol Phys, 2014, 89(4): 722-728.
69 Flechsig P, Dadrich M, Bickelhaupt S, et al. LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-beta and BMP-associated proinflammatory and proangiogenic signals[J]. Clin Cancer Res, 2012, 18(13): 3616-3627.
70 Rangarajan S, Locy ML, Luckhardt TR, et al. Targeted therapy for idiopathic pulmonary fibrosis: Where to now?[J]. Drugs, 2016, 76(3): 291-300.
71 Qin W, Liu B, Yi M, et al. Antifibrotic agent pirfenidone protects against development of radiation-induced pulmonary fibrosis in a murine model[J]. Radiat Res, 2018, 190(4): 396-403.
72 Simone NL, Soule BP, Gerber L, et al. Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study[J]. Radiat Oncol, 2007, 2: 19.
73 Takahashi S, Endo M, Fukuda Y, et al. Nintedanib-induced delayed mucosal healing after adjuvant radiation in a case of oropharyngeal carcinoma[J]. Case Rep Oncol, 2022, 15(2): 776-782.
74 邹 晶, 徐兴祥, 王大新, 等. 肺癌放化疗“实时”疗效评估方法的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(4): 360-363.